Sarah L. Anderson, PharmD (she/her)

Remember to join us Thursday, March 12, at 7:00 PM EDT, for our #Hemoglobinopathy live virtual symposium! bit.ly/GeneTherapy-26…

Gain expert strategies on addressing practical aspects of #CART therapy, such as counseling, referral, AE management, and care coordination with @SagheerTiba and Amanda Yepes, PharmD, BCOP after #HOPA2026 #HemOnc 📅 4/1 at 7 PM EST 🔗 bit.ly/CARTVirtual26-T

Join us at #RPA2026 for this important #IgA #nephropathy symposium! #MedEd #kidneydisease #nephrology

Treatment selection/sequencing in HR+, HER2- MBC is multifactorial. Drs. @jhaveri_komal, @curijoey, and @elmayermd provide insights on treatment planning through real cases to guide confident clinical decisions. Watch the discussion from #SABCS25 bit.ly/4lvYrrg #MedEd

AASLD is proud to collaborate with leading global organizations on a new consensus document guiding the diagnosis, staging, and management of alpha-1 antitrypsin deficiency–associated liver disease in adults. #LiverTwitter @AmerGastroAssn @EASLnews View the consensus document in @AGA_Gastro. bit.ly/4snHRNl

Are you up on the latest data for #livercancer care? Watch Drs. Galle, El-Khoueiry (@DrElkhoueiry), & Kelley discuss how recent systemic therapy developments are changing tx paradigms across the disease spectrum: bit.ly/47jSwQ2 #GI26 #oncology #MedEd #HCC @BlueFaeryLiver

Putting Pharmacist-Led Solutions Into Practice: Master modern targeted and immune-based therapies with Drs. Hayward, MacDonald, and Zacholski (@ErinHZPharmD) in advanced #EndometrialCancer and #OvarianCancer on 3/27 at 11:30 AM CDT. Register: bit.ly/GynOncNOLA26-T #HOPA2026

Perioperative immunotherapy is reshaping resectable #Gastric & #GEJC care! 🚀 Join @PeerView this Thur, 3/5 at #SSO2026. 💬Learn from Drs. Yelena Janjigian (@yjanjigianmd) & Marion Liu (@Mliu_MD). Refine patient selection & boost team collaboration‼️ 🔗 bit.ly/26GEJ-T

Pharmacists play a key role in advancing #RSV vaccination 🚨 Learn how with @JayCDoesID & Richard Dang, PharmD of @USCMann at this live #APhA2026 session on 3/28 at 6:00 AM PDT: bit.ly/RSVPharmLA26-T #ForPharmacy #InfectiousDisease

Your #BreastCancer 2026 game plan? 🎯 Join @PeerView at #SSO2026 this Thurs 3/5 💬 Ask, challenge, learn‼️ With Drs. Laura S. Dominici (@dr_laurad), Kamel Abou Hussein & Olga Kantor 🚀 Register: bit.ly/26EBC-T

Join Dr. Richard Dang and I at #APhA2026 on 3/28 at 6:30 AM PDT for a @PeerView live breakfast symposium on practical strategies to improve RSV vaccine uptake—attend in person or virtually: bit.ly/RSVPharmLA26-T #MedEd #Vaccines

🚨 #RSV vaccine rates are too low. We can do better‼️ ✅ Show up ✅ Speak up ✅ Change outcomes Join @PeerView at #APhA2026 on 3/28 with Drs. Abdul-Mutakabbir (@JayCDoesID) & Dang (@USCMann) for practical strategies to improve RSV vaccine uptake. 🔗 bit.ly/RSVPharmLA26-T

📢 Calling all #pharmacists! You don't want to miss this @PeerView #RSV #vaccine program at #APhA2026! #vaccines #vaccineswork #stopRSV

Join Haydar Frangoul, MD, MS (@hfrangoul) and Akshay Sharma, MBBS, MSc (@AkshaySharmaMD) on 3/12 at 7:00 PM EDT for a #Hemoglobinopathy #MedEd event: bit.ly/GeneTherapy-26… #HemeOnc #SCD #Thalassemia

#PAR isn’t “just allergies.” 🌬️ It’s chronic, underestimated, and evolving. ✨ IL-13 biologics are changing what’s possible. 🎤 Join @PeerView at #AAAAI25 featuring Drs. Ellen Sher, @CFaaoa, & Steven Weinstein 📅 Sat, Feb 28 | 6:30 PM EST 👉 bit.ly/Par-26-T #Allergy

Join Drs. Barbara Burtness, @AartiBhatiaMD, and Ranee Mehra from the University of Maryland for an in-person or virtual #HNSCC program exploring approaches to care for patients with recurrent/metastatic head and neck squamous cell carcinoma. RSVP: bit.ly/MHNCS26-T @SmilowCancer @PeerView

🔥 Your #NSCLC questions—answered. Join @PeerView’s live TownHall at IASLC #TTLC26 to discuss immune-based and targeted therapies with expert faculty. 🗓️ Feb 19 | 7:45 PM PST | In person or virtual 🔗 bit.ly/LungCancer26-T #MedEd #Oncology

🚀 The future of #HNSCC care is here. Join @PeerView 2/19 | 12 PM PST at ASTRO #MHNCS26 for expert, case-based insights on bispecific antibodies. 🎙️ Barbara Burtness, MD | @AartiBhatiaMD | Ranee Mehra, MD 📍 Palm Desert or virtual 🔗 bit.ly/MHNCS26-T #MedEd @HNCA

Want to stay ahead in #RCC care? Join me, @montypal, and @crisuarez08 live San Fran or online 2/26 at 7:00 PM PST for Unlocking the Potential of Modern RCC Therapies. Discover practical strategies to tailor tx & improve outcomes: bit.ly/RCC-SF26-T @PeerView @KidneyCancer

The OCEANIC STROKE trial at #ISC26 showed Asundexian was associated with a reduced occurrence of ischemic stroke in patients with non-cardioembolic ischemic stroke or high-risk TIA receiving antiplatelet therapy, without an increase in major bleeding compared with placebo. Here is @BraydonDymm’s take on the data.